In the Pink Sheet, Catalyst’s Nancy Myers discusses the Administration’s Operation Warp Speed and conflicts of interest. Though “the commissioner doesn’t approve drugs or vaccines. That is really left up the center directors and the reviewers and the scientists at FDA.” She argued that FDA is experiencing its own warp speed and that the Commissioner needed to make his own decision where his time is best spent. With Dr. Janet Woodcock’s expertise and experience she could drive Operation Warp Speed progress.
Read the full article here (subscription required).